Terminal cancer is bound to affect 39.6% of Americans at some point in their lives. Over 5,500 infants in the U.S. die each year from birth defects. Think of all families and lives that are lost. Now ask yourself, what if we had the opportunity to save those people, but it came with a price?
In the first trimester, a pregnant woman’s doctor begins screening and testing for birth defects. Let’s say, for example, that your child is diagnosed with Down Syndrome. Crispr Cas9 could be injected into the fetus and within a short time period save them from disability. Crispr could also be used, within the womb, to modify a child’s physical appearance, characteristics, and other traits.